IME Medical Electro spinning changes its name to VIVOLTA with a particular focus on women’s health.
FREMONT, CA: VIVOLTA, a global leader in nanofiber-based medical devices, has changed its name from IME Medical Electro spinning to VIVOLTA.
The company, which is a spin-out of the Technical University Eindhoven, has evolved from an advanced independent equipment manufacturer with global distribution to a full-service medical solution provider and scientific partner, developing and commercialising game-changing products in the fields of medical devices, tissue engineering, and drug delivery solutions over the past nearly fifteen years.
“Over the past few years, our business has evolved significantly from a High-Tech equipment builder into a MedTech company. Our new name, VIVOLTA, completes this transformation and supports our exciting new vision. We aim to help our customers bring first-in-class electrospun nanofiber-based medical devices, tissue engineering products, and drug delivery solutions to patients, thereby guiding the body to heal itself.” said Judith Heikoop, Chief Executive Officer at VIVOLTA.
“Our company has reached major milestones during the last couple of years, having built a clinical grade facility with a high-end GLP Laboratory and set of cleanrooms, enabling the production of Class I, II and III medical devices. We launched our groundbreaking MediSpinïƒ¢ technology platform for the controlled large-scale production of well-defined nanofiber-based products. Recently we obtained ISO 13485 certification and were the proud co-author of the first standard on fiber-based medical scaffolds, published by ASTM International.” Heikoop added.
VIVOLTA's groundbreaking technological platform, the MediSpin®, is set to offer novel nanofiber-based solutions to the worldwide market. This completely automated, large-scale manufacturing platform for high-quality nanofiber-based medical devices for clinical application is the first of its type. Production is consistent, repeatable, and scalable thanks to the MediSpin® technology platform. Importantly, the MediSpin® platform, which seven patent families cover, complies with the standards outlined in the first ASTM standard for fiber-based medical scaffolds (F3510-21), which is co-authored by VIVOLTA.
Judith heiloop concludes, “I am extremely proud of what we have achieved so far, and I am looking forward to serving the fields of nanofiber medical devices, tissue engineering, and drug delivery solutions with our highly motivated team and state-of-the-art MediSpin® manufacturing platform.”